Processing .....please wait.. 
The article has been forwarded.... 
GSK mulls discovery unit in India
By agencies
|
Monday, 13 June 2005, 19:30 IST
NEW DELHI: British pharma major GlaxoSmithKline International is considering setting up its own drug discovery unit in India, besides doing more clinical trials in the post product patents regime.
"With the passing of the patents law, we see a distinct business atmosphere in India, as it opens a new chapter in its intellectual property laws. We have partnerships and might consider the prospect of our discovery unit," GSK International president Russel Greig said.
"It raises the prospects of doing more clinical trials, which will be mutually beneficial. We will bring in expertise and knowledge and innovation faster into the Indian market place," he said, when asked about the role envisaged about GSK India.
On the shutting down of GSK's plants in India, Greig said, "With globalization every company is trying to reduce the manufacturing cost by moving to high quality and relatively low-cost markets. And we are no different.
"We have been happy with the quality and cost of manufacturing in India, as we undertake a constant review of the manufacturing plants. We have to take 3, 5, 10 year's horizon".
But he declined to confirm whether the company was considering the possibility of setting up more production bases in India for servicing other markets.